A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.
The study – the first trial to publish five-year results from SBRT treatment for prostate cancer – found a 98.6 percent cure rate with SBRT, a noninvasive form of radiation treatment that involves high-dose radiation beams entering the body through various angles and intersecting at the desired target. It is a state-of-the-art technology that allows for a concentrated dose to reach the tumor while limiting the radiation dose to surrounding healthy tissue.
“The high cure rate is striking when compared to the reported five-year cure rates from other approaches like surgery or conventional radiation, which range between 80 to 90 percent, while the side effects of this treatment are comparable to other types of treatment,” said Dr. Raquibul Hannan, Assistant Professor of Radiation Oncology and lead author for the study. “What we now have is a more potent and effective form of completely noninvasive treatment for prostate cancer, conveniently completed in five treatments.”
Conventional treatment options for early stage prostate cancer include:
- Prostatectomy, the surgical removal of the prostate gland, which can be done with minimally invasive techniques and robotic assistance;
- Brachytherapy, in which doctors implant numerous small radioactive seeds about the size of a grain of rice into the prostate gland using multiple large needles inserted through the skin in the operating room. Once implanted, the seeds release their radioactivity directly into the prostate gland; and
- External beam radiation, which involves 42 to 45 treatments administered over two or more months, five days a week.
“The current form of radiation is 44 treatments given over nine weeks. In contrast, the SBRT therapy we used allows the delivery of highly focused radiation in only five treatments, allowing patients to return to their normal lives more quickly,” said senior author Dr. Robert Timmerman, Director of the Annette Simmons Stereotactic Treatment Center at UT Southwestern, and Professor and Vice Chairman of the Department of Radiation Oncology. “SBRT is both more convenient and has increased potency.”
UT Southwestern served as the lead site for the multi-institutional clinical trial, which involved first-time prostate cancer patients diagnosed with stage I or stage II (low and intermediate risk) prostate cancer. A total of 91 patients were treated prospectively and followed for five years, with only one patient experiencing a recurrence of his cancer. The findings are published in the European Journal of Cancer.
Terry Martin of McKinney, Texas, – about an hour outside Dallas – said the fewer number of treatments was a compelling advantage when he was evaluating treatment options.
“I live 45 minutes away from UT Southwestern. The difference between being treated five times versus 44 times is enormous,” said Mr. Martin, a retired airline pilot. “I felt that I was back to normal just 10 days after finishing treatment.”
In addition to shorter treatment times, researchers found that side effects were not necessarily different compared to other forms of prostate cancer treatment. In the short term, the side effects of SBRT can include urinary issues (urgency, frequency and burning) and rectal irritation, which are often temporary and reverse within four weeks of treatment. Researchers found a small risk of longer-term urinary and rectal complications, which is also comparable to conventional treatments. Decrease in erectile function was seen in 25 percent of patients, fewer than with conventional radiation or surgery, said Dr. Hannan.
Learn more: Research shows 98% cure rate for prostate cancer using Stereotactic Body Radiation Therapy
The Latest on: Stereotactic Body Radiation Therapy
[google_news title=”” keyword=”Stereotactic Body Radiation Therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stereotactic Body Radiation Therapy
- Radiotherapy with hormone therapy can help some advanced prostate cancer patients avoid chemotherapyon May 8, 2024 at 10:51 pm
Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, ...
- New trial finds radiotherapy combined with hormone therapy can help some advanced prostate cancer patients avoid chemotherapyon May 8, 2024 at 4:22 am
Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, ...
- Prostate cancer hope as patients could get painless treatment instead of chemoon May 6, 2024 at 1:33 pm
Currently patients with a form of the disease which has spread to one or two other parts of the body are assumed to be resistant to milder hormone therapy drugs ...
- Science & Medicine: Revolutionizing prostate cancer treatmenton April 27, 2024 at 8:59 am
Prostate cancer is the most common cancer diagnosed in men, and the five year survival rate is 97%.
- Emerging Application of Stereotactic Body Radiation Therapy for Gynecologic Malignancieson April 22, 2024 at 4:59 pm
Stereotactic body radiation therapy distinguishes itself from other techniques of radiotherapy in its requirements of more rigid patient immobilization, respiratory motion control, sophisticated ...
- WOO Network trials investigate innovative treatments for liver, head and neck cancerson April 20, 2024 at 10:44 pm
A new round of clinical trials supported by the Ontario Institute for Cancer Research (OICR) will harness a unique opportunity to test some of the newest treatment strategies for a range of different ...
- Stereotactic Body Radiation Therapy for Prostate Canceron April 14, 2024 at 5:00 pm
‡ Risk criteria is not available. § Grade 3 or more. ¶ Including IMRT. # Result from nadir+2 is shown in this table. †† n = 101 for toxicity assessment. ‡‡ Once a week over 29 days.
- Innovations In Radiation Therapy Revolutionise Cancer Treatmenton March 31, 2024 at 5:36 am
Techniques such as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and proton therapy enable clinicians to deliver high doses of radiation directly to the ...
- Radiation Therapy for Head and Neck Canceron August 15, 2020 at 7:49 pm
Radiation therapy is a cancer treatment that involves sending high ... It is particularly beneficial for people who did not have surgery to remove a tumor. Stereotactic body radiotherapy (SBRT) ...
- Stereotactic Body Radiotherapy (SBRT)on August 9, 2020 at 2:57 am
Stereotactic body radiotherapy (SBRT) also known as stereotactic ablative ... tumors anywhere in the body with sub-millimeter accuracy. CHI Baylor St. Luke’s Radiation Therapy and CyberKnife Center is ...
via Bing News